Global Custom Recombinant Antibody Production Service Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08252348

Publication Date:

August 28, 2024

Pages:

134

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Custom Recombinant Antibody Production Service market size was valued at US$ million in 2023. With growing demand in downstream market, the Custom Recombinant Antibody Production Service is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Custom Recombinant Antibody Production Service market. Custom Recombinant Antibody Production Service are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Custom Recombinant Antibody Production Service. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Custom Recombinant Antibody Production Service market.
Key Features:
The report on Custom Recombinant Antibody Production Service market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Custom Recombinant Antibody Production Service market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibody (mAb) Production, Polyclonal Antibody (pAb) Production), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Custom Recombinant Antibody Production Service market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Custom Recombinant Antibody Production Service market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Custom Recombinant Antibody Production Service industry. This include advancements in Custom Recombinant Antibody Production Service technology, Custom Recombinant Antibody Production Service new entrants, Custom Recombinant Antibody Production Service new investment, and other innovations that are shaping the future of Custom Recombinant Antibody Production Service.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Custom Recombinant Antibody Production Service market. It includes factors influencing customer ' purchasing decisions, preferences for Custom Recombinant Antibody Production Service product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Custom Recombinant Antibody Production Service market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Custom Recombinant Antibody Production Service market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Custom Recombinant Antibody Production Service market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Custom Recombinant Antibody Production Service industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Custom Recombinant Antibody Production Service market.
Market Segmentation:
Custom Recombinant Antibody Production Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Monoclonal Antibody (mAb) Production
Polyclonal Antibody (pAb) Production
Segmentation by application
Pharmaceutics
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
evitria
ProSci
GenScript
RayBiotech
Cygnus Technologies
Cayman Chemical
Boster Bio
Bon Opus Biosciences
Biomatik
Abcam
Bio-Rad
Creative Biolabs
ProteoGenix
Sino Biological
Absolute Antibody
ProMab Biotechnologies
ACROBiosystems
Cusabio Technology
Covance

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Custom Recombinant Antibody Production Service Market Size 2019-2030
2.1.2 Custom Recombinant Antibody Production Service Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Custom Recombinant Antibody Production Service Segment by Type
2.2.1 Monoclonal Antibody (mAb) Production
2.2.2 Polyclonal Antibody (pAb) Production
2.3 Custom Recombinant Antibody Production Service Market Size by Type
2.3.1 Custom Recombinant Antibody Production Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Custom Recombinant Antibody Production Service Market Size Market Share by Type (2019-2024)
2.4 Custom Recombinant Antibody Production Service Segment by Application
2.4.1 Pharmaceutics
2.4.2 Scientific Research
2.4.3 Others
2.5 Custom Recombinant Antibody Production Service Market Size by Application
2.5.1 Custom Recombinant Antibody Production Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Custom Recombinant Antibody Production Service Market Size Market Share by Application (2019-2024)
3 Custom Recombinant Antibody Production Service Market Size by Player
3.1 Custom Recombinant Antibody Production Service Market Size Market Share by Players
3.1.1 Global Custom Recombinant Antibody Production Service Revenue by Players (2019-2024)
3.1.2 Global Custom Recombinant Antibody Production Service Revenue Market Share by Players (2019-2024)
3.2 Global Custom Recombinant Antibody Production Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Custom Recombinant Antibody Production Service by Regions
4.1 Custom Recombinant Antibody Production Service Market Size by Regions (2019-2024)
4.2 Americas Custom Recombinant Antibody Production Service Market Size Growth (2019-2024)
4.3 APAC Custom Recombinant Antibody Production Service Market Size Growth (2019-2024)
4.4 Europe Custom Recombinant Antibody Production Service Market Size Growth (2019-2024)
4.5 Middle East & Africa Custom Recombinant Antibody Production Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Custom Recombinant Antibody Production Service Market Size by Country (2019-2024)
5.2 Americas Custom Recombinant Antibody Production Service Market Size by Type (2019-2024)
5.3 Americas Custom Recombinant Antibody Production Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Custom Recombinant Antibody Production Service Market Size by Region (2019-2024)
6.2 APAC Custom Recombinant Antibody Production Service Market Size by Type (2019-2024)
6.3 APAC Custom Recombinant Antibody Production Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Custom Recombinant Antibody Production Service by Country (2019-2024)
7.2 Europe Custom Recombinant Antibody Production Service Market Size by Type (2019-2024)
7.3 Europe Custom Recombinant Antibody Production Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Custom Recombinant Antibody Production Service by Region (2019-2024)
8.2 Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Custom Recombinant Antibody Production Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Custom Recombinant Antibody Production Service Market Forecast
10.1 Global Custom Recombinant Antibody Production Service Forecast by Regions (2025-2030)
10.1.1 Global Custom Recombinant Antibody Production Service Forecast by Regions (2025-2030)
10.1.2 Americas Custom Recombinant Antibody Production Service Forecast
10.1.3 APAC Custom Recombinant Antibody Production Service Forecast
10.1.4 Europe Custom Recombinant Antibody Production Service Forecast
10.1.5 Middle East & Africa Custom Recombinant Antibody Production Service Forecast
10.2 Americas Custom Recombinant Antibody Production Service Forecast by Country (2025-2030)
10.2.1 United States Custom Recombinant Antibody Production Service Market Forecast
10.2.2 Canada Custom Recombinant Antibody Production Service Market Forecast
10.2.3 Mexico Custom Recombinant Antibody Production Service Market Forecast
10.2.4 Brazil Custom Recombinant Antibody Production Service Market Forecast
10.3 APAC Custom Recombinant Antibody Production Service Forecast by Region (2025-2030)
10.3.1 China Custom Recombinant Antibody Production Service Market Forecast
10.3.2 Japan Custom Recombinant Antibody Production Service Market Forecast
10.3.3 Korea Custom Recombinant Antibody Production Service Market Forecast
10.3.4 Southeast Asia Custom Recombinant Antibody Production Service Market Forecast
10.3.5 India Custom Recombinant Antibody Production Service Market Forecast
10.3.6 Australia Custom Recombinant Antibody Production Service Market Forecast
10.4 Europe Custom Recombinant Antibody Production Service Forecast by Country (2025-2030)
10.4.1 Germany Custom Recombinant Antibody Production Service Market Forecast
10.4.2 France Custom Recombinant Antibody Production Service Market Forecast
10.4.3 UK Custom Recombinant Antibody Production Service Market Forecast
10.4.4 Italy Custom Recombinant Antibody Production Service Market Forecast
10.4.5 Russia Custom Recombinant Antibody Production Service Market Forecast
10.5 Middle East & Africa Custom Recombinant Antibody Production Service Forecast by Region (2025-2030)
10.5.1 Egypt Custom Recombinant Antibody Production Service Market Forecast
10.5.2 South Africa Custom Recombinant Antibody Production Service Market Forecast
10.5.3 Israel Custom Recombinant Antibody Production Service Market Forecast
10.5.4 Turkey Custom Recombinant Antibody Production Service Market Forecast
10.5.5 GCC Countries Custom Recombinant Antibody Production Service Market Forecast
10.6 Global Custom Recombinant Antibody Production Service Forecast by Type (2025-2030)
10.7 Global Custom Recombinant Antibody Production Service Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 evitria
11.1.1 evitria Company Information
11.1.2 evitria Custom Recombinant Antibody Production Service Product Offered
11.1.3 evitria Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 evitria Main Business Overview
11.1.5 evitria Latest Developments
11.2 ProSci
11.2.1 ProSci Company Information
11.2.2 ProSci Custom Recombinant Antibody Production Service Product Offered
11.2.3 ProSci Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 ProSci Main Business Overview
11.2.5 ProSci Latest Developments
11.3 GenScript
11.3.1 GenScript Company Information
11.3.2 GenScript Custom Recombinant Antibody Production Service Product Offered
11.3.3 GenScript Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GenScript Main Business Overview
11.3.5 GenScript Latest Developments
11.4 RayBiotech
11.4.1 RayBiotech Company Information
11.4.2 RayBiotech Custom Recombinant Antibody Production Service Product Offered
11.4.3 RayBiotech Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 RayBiotech Main Business Overview
11.4.5 RayBiotech Latest Developments
11.5 Cygnus Technologies
11.5.1 Cygnus Technologies Company Information
11.5.2 Cygnus Technologies Custom Recombinant Antibody Production Service Product Offered
11.5.3 Cygnus Technologies Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cygnus Technologies Main Business Overview
11.5.5 Cygnus Technologies Latest Developments
11.6 Cayman Chemical
11.6.1 Cayman Chemical Company Information
11.6.2 Cayman Chemical Custom Recombinant Antibody Production Service Product Offered
11.6.3 Cayman Chemical Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Cayman Chemical Main Business Overview
11.6.5 Cayman Chemical Latest Developments
11.7 Boster Bio
11.7.1 Boster Bio Company Information
11.7.2 Boster Bio Custom Recombinant Antibody Production Service Product Offered
11.7.3 Boster Bio Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boster Bio Main Business Overview
11.7.5 Boster Bio Latest Developments
11.8 Bon Opus Biosciences
11.8.1 Bon Opus Biosciences Company Information
11.8.2 Bon Opus Biosciences Custom Recombinant Antibody Production Service Product Offered
11.8.3 Bon Opus Biosciences Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bon Opus Biosciences Main Business Overview
11.8.5 Bon Opus Biosciences Latest Developments
11.9 Biomatik
11.9.1 Biomatik Company Information
11.9.2 Biomatik Custom Recombinant Antibody Production Service Product Offered
11.9.3 Biomatik Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biomatik Main Business Overview
11.9.5 Biomatik Latest Developments
11.10 Abcam
11.10.1 Abcam Company Information
11.10.2 Abcam Custom Recombinant Antibody Production Service Product Offered
11.10.3 Abcam Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Abcam Main Business Overview
11.10.5 Abcam Latest Developments
11.11 Bio-Rad
11.11.1 Bio-Rad Company Information
11.11.2 Bio-Rad Custom Recombinant Antibody Production Service Product Offered
11.11.3 Bio-Rad Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bio-Rad Main Business Overview
11.11.5 Bio-Rad Latest Developments
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Information
11.12.2 Creative Biolabs Custom Recombinant Antibody Production Service Product Offered
11.12.3 Creative Biolabs Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Creative Biolabs Main Business Overview
11.12.5 Creative Biolabs Latest Developments
11.13 ProteoGenix
11.13.1 ProteoGenix Company Information
11.13.2 ProteoGenix Custom Recombinant Antibody Production Service Product Offered
11.13.3 ProteoGenix Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 ProteoGenix Main Business Overview
11.13.5 ProteoGenix Latest Developments
11.14 Sino Biological
11.14.1 Sino Biological Company Information
11.14.2 Sino Biological Custom Recombinant Antibody Production Service Product Offered
11.14.3 Sino Biological Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Sino Biological Main Business Overview
11.14.5 Sino Biological Latest Developments
11.15 Absolute Antibody
11.15.1 Absolute Antibody Company Information
11.15.2 Absolute Antibody Custom Recombinant Antibody Production Service Product Offered
11.15.3 Absolute Antibody Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Absolute Antibody Main Business Overview
11.15.5 Absolute Antibody Latest Developments
11.16 ProMab Biotechnologies
11.16.1 ProMab Biotechnologies Company Information
11.16.2 ProMab Biotechnologies Custom Recombinant Antibody Production Service Product Offered
11.16.3 ProMab Biotechnologies Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 ProMab Biotechnologies Main Business Overview
11.16.5 ProMab Biotechnologies Latest Developments
11.17 ACROBiosystems
11.17.1 ACROBiosystems Company Information
11.17.2 ACROBiosystems Custom Recombinant Antibody Production Service Product Offered
11.17.3 ACROBiosystems Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 ACROBiosystems Main Business Overview
11.17.5 ACROBiosystems Latest Developments
11.18 Cusabio Technology
11.18.1 Cusabio Technology Company Information
11.18.2 Cusabio Technology Custom Recombinant Antibody Production Service Product Offered
11.18.3 Cusabio Technology Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Cusabio Technology Main Business Overview
11.18.5 Cusabio Technology Latest Developments
11.19 Covance
11.19.1 Covance Company Information
11.19.2 Covance Custom Recombinant Antibody Production Service Product Offered
11.19.3 Covance Custom Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Covance Main Business Overview
11.19.5 Covance Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂